ArticleJournal of cancer research and clinical oncology2013

Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Aykan A Karabudak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.